Mouse models of graft-versus-host disease: advances and limitations
Open Access
- 1 May 2011
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 4 (3), 318-333
- https://doi.org/10.1242/dmm.006668
Abstract
The limiting factor for successful hematopoietic stem cell transplantation (HSCT) is graft-versus-host disease (GvHD), a post-transplant disorder that results from immune-mediated attack of recipient tissue by donor T cells contained in the transplant. Mouse models of GvHD have provided important insights into the pathophysiology of this disease, which have helped to improve the success rate of HSCT in humans. The kinetics with which GvHD develops distinguishes acute from chronic GvHD, and it is clear from studies of mouse models of GvHD (and studies of human HSCT) that the pathophysiology of these two forms is also distinct. Mouse models also further the basic understanding of the immunological responses involved in GvHD pathology, such as antigen recognition and presentation, the involvement of the thymus and immune reconstitution after transplantation. In this Perspective, we provide an overview of currently available mouse models of acute and chronic GvHD, highlighting their benefits and limitations, and discuss research and clinical opportunities for the future.Keywords
This publication has 144 references indexed in Scilit:
- Have we made progress in the management of chronic graft-vs-host disease?Best Practice & Research Clinical Haematology, 2010
- Single Round of Antigen Receptor Signaling Programs Naive B Cells to Receive T Cell HelpImmunity, 2010
- Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow TransplantTransplantation and Cellular Therapy, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complexClinical and Experimental Immunology, 2009
- In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestationsBlood, 2009
- Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host diseaseExperimental Hematology, 2008
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved IssuesTransplantation and Cellular Therapy, 2008
- Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull miceExperimental Hematology, 2007
- Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environmentBlood, 2007